Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  J ANTIINFECTIVES FOR SYSTEMIC USE
    J05 ANTIVIRALS FOR SYSTEMIC USE
      J05A DIRECT ACTING ANTIVIRALS
        J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
          J05AF13 Tenofovir alafenamide [DG:DG01223]
            D10428  Tenofovir alafenamide (USAN/INN)

Drug groups [BR:br08330]
  Antiviral
    DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
      DG01223  Tenofovir
        D10428  Tenofovir alafenamide
    DG03107  Anti-HIV agent
      DG01656  HIV reverse transcriptase inhibitor
        DG01223  Tenofovir
          D10428  Tenofovir alafenamide
  Transporter substrate
    DG01665  ABCB1 substrate
      D10428  Tenofovir alafenamide
    DG01913  ABCG2 substrate
      D10428  Tenofovir alafenamide

Antimicrobials [BR:br08307]
  Antivirals
    Genome replication inhibitor
      HBV reverse transcriptase inhibitor
        D10428  Tenofovir alafenamide (USAN/INN)

Antimicrobials abbreviations [BR:br08327]
  Antivirals
    Genome replication inhibitor
      HBV reverse transcriptase inhibitor
        D10428  Tenofovir alafenamide (USAN/INN)	TAF	TAF

New drug approvals in Europe [br08329.html]
  D10428

Drug metabolizing enzymes and transporters [br08309.html]
  D10428

Prodrugs [br08324.html]
  D10428